Karvy Stock Broking has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Dishman Pharmaceuticals December quarter sales are expected to go up by 5.3% at Rs 235.3 crore, Year-on-Year, (YoY) basis.
The company's net profit is expected to go down by 47.1% at Rs 17.5 crore on YoY basis.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
